Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Gynecologic 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Testicular Neoplasms 22Kidney Neoplasms 18Ovarian Neoplasms 17Testicular Germ Cell Tumor 16Urinary Bladder Neoplasms 14Wilms Tumor 13Sarcoma 13Teratoma 10Central Nervous System Neoplasms 10Neuroectodermal Tumors, Primitive, Peripheral 9Neuroblastoma 9Carcinoma, Renal Cell 9Prostatic Neoplasms 8Endodermal Sinus Tumor 8Seminoma 7Medulloblastoma 7Carcinoma, Embryonal 7Retinoblastoma 6Osteosarcoma 6Astrocytoma 6Ovarian Germ Cell Cancer 5Optic Nerve Glioma 5Neoplasm Metastasis 5Melanoma 5Lymphoma 5Recurrence 4Liver Neoplasms 4Head and Neck Neoplasms 4Familial ependymoma 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

cixutumumab 1Thiotepa 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Erlotinib Hydrochloride 1Busulfan 1Bone Marrow Transplantation 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Filgrastim × Genitourinary × Clear all
NCT00003926 2017-11-29

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
13 enrolled
CNSGastrointestinalGenitourinaryGynecologicOther solid neoplasmSarcoma

Ovarian Germ Cell Cancer, Astrocytoma, Brain Neoplasms, Chordoma, Ependymoma, Glioma, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Neuroblastoma, Ovarian Neoplasms, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Hepatoblastoma, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡